首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 超音波 > Aloka醫用儀器有限公司:企業商業智慧報告
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

Aloka醫用儀器有限公司:企業商業智慧報告

Aloka Medical Device Company Intelligence Report

出版商 Espicom Business Intelligence
出版日期 2010年11月 商品編碼 136807
內容資訊 英文 Pages: 18
價格
US $ 515 Hard Copy
US $ 515 PDF by E-mail (Single user license)
US $ 515 Web Access (Single user license)


Aloka醫用儀器有限公司:企業商業智慧報告 是由出版商Espicom Business Intelligence在2010年11月所出版的。 這份英文市場調查報告書包含Pages: 18 價格從美金515起跳。

簡介

醫用超音波儀器製造商Aloka醫用儀器有限公司於1960年率先全球發展了診斷用超音波設備,1983年開發了第一個彩色都卜勒系統。東京本部2010年3月底連結銷售已達458億1,100萬日圓,估計為6億6,200萬日圓。

本報告為,匯整本公司企業資訊及財務實績、其他主要競合公司簡介、主要產品及研發趨勢、製造銷售趨勢、M&A趨勢等,以下列摘要形式闡述。

概要

財務回顧

  • 2010年前半季財務實績
  • 5年間財務數據
  • 今後展望

策略性矚目領域

產品

  • 醫療用電子設備
    • 診斷用超音波設
    • 傳感器
    • 骨密度測量儀
  • 醫療用分析設備
  • 一般分析設備

研究開發

  • 新技術

製造、銷售

  • 製造
  • 銷售

合約

合併、收購

主要企業活動

圖表

目錄

Abstract

Summary

Medical Device Company Intelligence Reports provide a full review of the company' s activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.

META Description

The history of Aloka began in 1950 when the medical equipment department of Japan Radio Company became an independent company, Medical and Physical Institute Co Ltd. In 1976, the company' s name was changed to Aloka, which means "ray of hope" in ancient Sanskrit.

Aloka' s operations are divided within three product segments: Electronic Medical Systems (including diagnostic ultrasound systems, bone densitometry systems and medical treatment and surgery systems), General Analysis Systems (including radiation measuring instruments, radio control instruments, analysis systems using radiation and bio-related systems) and Medical Analysis Systems (laboratory test systems, pipettors, and emission and spectroscopic analysis systems). This profile focuses on the Electronic Medical Systems activities.

As a manufacturer of medical ultrasound equipment, Aloka' s most significant achievements include the development of the world' s first diagnostic ultrasound system - the SSD-2 - in 1960 and the first Colour Doppler system in 1983. Aloka' s worldwide headquarters is located in Tokyo, Japan. It operates 40 domestic and 16 overseas business establishments, including subsidiaries. The company' s US headquarters is located in Wallingford, Connecticut, and its European headquarters is in Zug, Switzerland. Aloka exports its products to more than 150 countries.

In 1992, Aloka formed a joint venture in Shanghai, China. The joint venture, Shanghai Aloka Medical Equipment Co Ltd, was the first Sino-Japanese joint venture producing medical ultrasonic diagnostic apparatus in China. A joint venture with Trivitron Medical Systems in India was established in April 2009 and is producing ultrasound systems for the Asian markets. Aloka' s competitors include Drager Medical, GE Healthcare, Siemens, Toshiba and Philips.

In the year ended 31st March 2010, Aloka generated net earnings of ¥662 million on consolidated net sales of ¥45,811 million.

Hitachi Medical is the second-largest shareholder in Aloka, with a 12.34% interest as of 31st March 2010.

This company report provides

Executive Summary

An overview of the company, including operating activities and latest results, at a glance key events and strategic focus.

Product Portfolio and R&D

The product section of the report focuses on the key aspects of the company' s portfolio and technology, covering core products, key brands, new products and analysis of the competition. Sales data, market size and future potentia is included where available.

The R&D section answers questions such as:

  • Where is the research based?
  • How much has been invested in R&D?
  • What is in the product pipeline?
  • What competing products are in development or already on the market?
  • What R&D agreements does the company have?
  • International Activities

The company' s revenues, assets and business activities by geographic region and country.

  • Appendices
  • Agreements
  • Mergers & Acquisitions
  • Key Corporate Events

Table of Contents

OVERVIEW

FINANCIAL REVIEW

  • Fiscal Year 2010 Financial Results
  • Five-Year Financial Data
  • Outlook

STRATEGIC FOCUS

PRODUCTS

  • Medical Electronic Systems
    • Diagnostic Ultrasound Systems
    • Transducers
    • Bone Densitometry Systems
      • AOS-100NW
      • DCS-600EX-III
  • Medical Analysis Systems
  • General Analysis Systems

RESEARCH AND DEVELOPMENT

  • New Technology

MANUFACTURING AND DISTRIBUTION

  • Manufacturing
  • Distribution

AGREEMENTS

  • RFA Medical
  • LI-COR Biosciences
  • Olympus Medical Systems
  • Xilinx
  • Hitachi Medical
  • Terason
  • SonoSite
  • Cedara Software
  • Hologic
  • Civco Medical Solutions

MERGERS AND ACQUISITIONS

  • Biomedic Belgium
  • Ecotron Holding

KEY CORPORATE EVENTS

List of Tables

  • SUMMARY OPERATING RESULTS
  • Recent Key Events
  • Aloka - Annual Financial Results, 2006-2010
  • Aloka - Annual Sales by Business Area, 2006-2010
  • Aloka - Annual Group Sales by Geographic Area, 2006-2010
  • Aloka - Five-Year Financial Summary
  • Aloka - Consolidated Net Sales and Operating Income Targets to 31st March 2013
  • Aloka - Annual R&D Expenditure, 2006-2010
  • Agreements Summary

List of Charts

  • Aloka - Annual Net Sales and Operating Income, 2006-2010
  • Aloka - Annual Sales by Business Area, 2006-2010
  • Aloka - Annual Sales by Geographic Area, 2006-2010
  • Aloka - Fiscal 2010 Sales by Business Area
Back to Top